The spleen

Published on 11/04/2015 by admin

Filed under Surgery

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1906 times

9

The spleen

Introduction

The history of the spleen, including surgery, anatomy and physiology, has been nicely detailed by McClusky et al. and will not be reviewed here.1,2 The spleen lies in the posterior left upper quadrant superior to the level of the costal margin. It is attached to adjacent structures via a series of ligaments including the splenophrenic, splenorenal, splenocolic and gastrosplenic ligaments.

The splenic artery arises from the coeliac trunk. Aberrant anatomy may include direct origination from the aorta, the superior mesenteric, middle colic or left gastric arteries. The splenic artery gives off pancreatic branches (the largest of which is the pancreatic magna) as well as the left gastroepiploic artery before branching and entering the spleen. The hilum may consist of a single, long splenic artery that branches late into the spleen, or an artery branching much earlier after its origin. Each artery ends in the sinusoids of a segment of the spleen. The spleen also receives blood flow from the short gastric vessels.

The splenic vein leaves the hilum and runs along the posterior aspect of the pancreas, providing venous drainage of the pancreas as well. It is joined by the inferior mesenteric vein before merging with the superior mesenteric vein to form the portal vein.

The spleen is composed of two or three lobes and two to ten segments with unique arterial supplies. Accessory spleens occur in approximately 10–15% of patients and are most commonly located near the splenic hilum, but may also be located at distant sites.

The spleen plays a significant role in fighting infections, particularly of encapsulated organisms. It also serves to filter aged blood cellular elements and removes intracellular inclusions, a process known as pitting. There are extensive T-cell and dendritic cell populations located primarily in the periarterial lymphatic sheaths. B cells are located in the lymphoid nodules while macrophages are distributed widely.

While the spleen provides important immune and housekeeping functions, it may also be a source of massive blood loss from trauma, excessive cellular destruction or sequestration, certain lymphomatous or myeloid diseases, symptomatic splenomegaly, or tumours. Splenic preservation is always preferred due to its many functions, but splenectomy may be necessary in these instances.

Postsplenectomy sepsis

Asplenic patients are at increased risk of developing overwhelming sepsis throughout their lives. This lifetime risk of postsplenectomy sepsis is approximately 0.02% for adults.3 In a recent large population-based study from Scotland, Kyaw et al.4 showed severe infection, defined as need for hospitalisation, occurred with an incidence of 7 per 100 person-years. The risk of overwhelming infection, defined as septicaemia or meningitis, was 0.89 per 100 person-years.

image

A high mortality is associated with overwhelming postsplenectomy infection and therefore prevention is of utmost importance. Davies et al.5 in 2002 revised the guidelines of the British Committee for Standards in Haematology published in 1996.6 Ideally, vaccinations should be administered a minimum of 2 weeks prior to splenectomy. Vaccinations should include polyvalent pneumococcal, haemophilus influenza type B and meningococcal C vaccines (Box 9.1). Pneumococcal vaccines should be repeated after 3–5 years.7 Shatz et al.8 prospectively studied 59 patients in a randomised fashion to determine the ideal timing of postoperative immunisation in patients who did not receive preoperative vaccines. Improved functional antibody responses to certain serotypes and serogroups were identified if immunisations were delayed for 14 days. Surgeons globally must be fastidious regarding compliance with vaccination guidelines.7,9

Trauma

The most common cause of splenic injury is blunt trauma.10 Rupture may also occur from penetrating trauma, iatrogenic injury or, rarely, diseases such as mononucleosis or typhoid. Management of splenic trauma has evolved significantly over the last several years. Non-operative management is used in 60–80% of blunt injury cases, with success rates of 95%.11 Initial management of all traumas should begin with primary and secondary surveys completed according to the Advanced Trauma Life Support guidelines.12 Diagnostic evaluation for splenic injury follows and is based on the haemodynamic status of the patient. Haemodynamically unstable patients should undergo rapid focused assessment by sonography for trauma (FAST).11,13 If FAST is not available or inconclusive, diagnostic peritoneal lavage may be used. Scant fluid on the FAST exam should prompt a search for other causes of shock. A large amount of intraperitoneal blood on FAST is an indication for emergent laparotomy. Currently, exploration for traumatic splenic injury is performed in an open fashion.

Haemodynamically stable patients with physical findings of abdominal trauma should undergo abdominal computed tomography (CT) to assess all potential injuries. A grading system for splenic injury based on CT findings has been developed by the American Association for the Surgery of Trauma (AAST)14 and is presented in Table 9.1. The decision to proceed to operative exploration, however, is not based solely upon these grades. All grades of injury have undergone successful non-operative management. Patients with higher grade injuries or age > 55 years, however, are at increased risk for failure of non-operative management and warrant a low threshold to proceed with operative intervention.1517

Table 9.1

American Association for the Study of Trauma (AAST) splenic injury scale based on CT criteria

Grade Injury description
I Haematoma Subcapsular, < 10% surface area
Laceration Capsular tear, < 1 cm parenchymal depth
II Haematoma Subcapsular, 10–50% surface area. Intraparenchymal, < 5 cm in diameter
Laceration 1–3 cm parenchymal depth, which does not involve a trabecular vessel
III Haematoma Subcapsular, > 50% surface area or expanding; ruptured subcapsular or parenchymal haematoma; intraparenchymal haematoma ≥ 5 cm or expanding
Laceration > 3 cm parenchymal depth, or involving trabecular vessels
IV Laceration Laceration involving segmental or hilar vessels producing major devascularisation (> 25% of spleen)
V Laceration Completely shattered spleen
Vascular Hilar vascular injury that devascularises spleen

Advance one grade for multiple injuries, up to grade III.

Indications for operative intervention in splenic trauma from the Society for Surgery of the Alimentary Tract (SSAT) Patient Care Guidelines18 are shown in Box 9.2. The group also suggests an aggressive non-operative approach for children < 14 years of age.

The use of selective arterial embolisation in the management of splenic trauma was initially described by Sclafani et al.19 but remains somewhat controversial. Protocol-driven strategies utilising both conservative and aggressive indications for implementing embolisation have yielded excellent results.20,21 Other groups, however, have highlighted difficulties in using CT grading systems and selective arterial embolisation, hence the conflict preventing widespread use.22,23

image

The decisions implicit in non-operative management are difficult and protocols will be useful to aid this process.14 Ultimately, decisions will be determined by clinical acumen and resources available at the centre treating the patient. The risk of postsplenectomy-related sepsis of 0.02% in adults3 will need to be weighed against the risks of transfusions, ongoing haemorrhage and late re-bleeding.

As many as 40% of splenectomies are performed as a result of iatrogenic splenic injury.24,25 Such injuries usually result from excess traction against either the splenic ligaments or adhesions to the spleen. The standard use of laparoscopic procedures may lower the risk of splenic injury by providing better visualisation, application of less traction, improved instrumentation for perisplenic dissection, and better control of capsular haemorrhage by the pressure of the pneumoperitoneum.26

Haemostatic control of splenic injuries begins with direct pressure. Haemostatic agents such as microfibrillar collagen, microporous polysaccharide hemispheres or injectable haemostatic matrices may be applied to aid haemostasis.27 Haemostatic instruments such as argon-beam coagulators may also be helpful. Ligation of selected arteries in the hilum may help control bleeding but potentially lead to a need for partial splenectomy. Splenorrhaphy and partial splenectomy have been described for splenic trauma; however, Holubar et al.28 showed the most important factor in preventing adverse outcome after iatrogenic splenic injury is prompt cessation of bleeding by whatever means. Splenectomy, while not desirable, is preferable to significant blood loss and should be performed when bleeding is excessive, if the patient cannot tolerate prolonged procedures, or if there are other factors that would make re-bleeding a greater risk than splenectomy.

Elective indications for splenectomy

Most recommendations for elective splenic surgery are based on level III or IV evidence. This is likely due to the relative rarity of diseases requiring splenectomy and the length of follow-up required to assess results. Recent literature reviews are referenced in this chapter when the supporting literature is composed largely of smaller non-prospective studies regarding a particular disease.

Immune thrombocytopenic purpura

The most common non-traumatic indication for splenectomy is immune thrombocytopenic purpura (ITP). This disease is characterised by low platelet count, normal bone marrow (increased megakaryocytes) and absence of other causes of thrombocytopenia. The destruction of platelets in this condition is mediated by platelet antibodies and the spleen is typically the site of destruction of the platelets. ITP remains a diagnosis of exclusion as tests for antiplatelet antibodies are not reliable indicators of the disease. The spleen is usually normal in size. Platelet function is also normal and while spontaneous bruising is common, severe haemorrhage is less likely unless platelet levels drop below 10 000.

image

Corticosteroid therapy is frequently instituted with platelet counts of 20 000–30 000.2931 Most patients will respond to medical therapy, at least initially. If counts respond and are sustained, the treatment is stopped and patients are observed. Intravenous immunoglobulin may be used to increase platelet counts temporarily, but the response lasts days to weeks only. Patients who require prolonged treatment or do not respond to medical therapy should be considered for splenectomy.

Approximately 80% of patients respond to splenectomy and 65–85% of patients sustain response long term.31 There is no widely accepted factor to predict response to splenectomy. If platelet counts drop after splenectomy, peripheral blood smears may show absence of nuclear inclusions (e.g. Howell–Jolley bodies) indicating residual splenic tissue. Nuclear medicine scans, magnetic resonance imaging or CT may help localise such remnants for re-exploration or embolisation. Mild to moderate degrees of thrombocytopenia without symptoms of purpura or bleeding postsplenectomy may be observed without resuming medical therapy.31

Hereditary spherocytosis

Hereditary spherocytosis results from abnormalities of membrane proteins, particularly spectrin. The degree of spectrin deficiency varies, as does the pattern of inheritance. Approximately 75% of cases demonstrate an autosomal dominant pattern. Autosomal recessive patients have a greater degree of spectrin deficiency and unlike the autosomal dominant patients do not respond to splenectomy. The disease is characterised by extravascular destruction of red cells, particularly in the spleen.33

image

Guidelines from the General Haematology Task Force of the British Committee for Standards in Haematology state that patients with severe disease presenting in childhood require splenectomy.34 If possible, surgery should be delayed until after 6 years of age to allow maturation of the immune system. Patients with mild disease may be safely observed. Otherwise, patients should be selected for splenectomy based on clinical symptoms and associated complications such as gallstones. Cholecystectomy should be performed if gallstones are present at the time of splenectomy.34

Several groups have reported the use of subtotal splenectomy for the treatment of hereditary spherocytosis and demonstrated amelioration of anaemia and maintenance of immune function. Mild to moderate haemolysis, however, may persist and gallstone formation and aplastic crises still developed in some patients.3537

Myeloid disease

Splenectomy plays little or no role in the treatment of chronic myelogenous leukaemias. Similarly, systemic therapy has replaced splenectomy as the primary treatment of hairy cell leukaemia, reserving splenectomy for refractory disease.

The spleen may reach truly massive proportions in primary myelofibrosis. This may lead to symptomatic splenomegaly, thrombocytopenia, hypercatabolic state with resultant high output heart failure, and forward flow portal hypertension. Medical therapy has delayed splenectomy until the last stages of the disease. Splenectomy may improve quality of life; however, it does not alter the course of the underlying disease. Mortality rates are high due to severe bleeding complications, heart failure and advanced stage of underlying disease at the time of splenectomy.

Haemangiomas

Haemangiomas are the most common benign neoplasm in the spleen. Small lesions (less than 4 cm) may be safely watched.41 Risks presented by larger haemangiomas are unclear. Therefore, splenectomy versus observation must be individually determined.

Cysts

Cystic lesions of the spleen are often classified as parasitic or non-parasitic. Cyst size and symptoms determine surgical intervention. Asymptomatic cysts with reassuring radiographic features may be observed. Cysts greater than 5 cm in diameter are at potentially higher risk of rupture, so intervention may be indicated either by laparoscopic deroofing or resection. Percutaneous drainage and alcohol ablation have also been used with unreliable results. Bacterial abscesses may be drained either by percutaneous or surgical means. Occasionally, splenectomy is required.42

Parasitic cysts are usually echinococcal in origin and the diagnosis is often confirmed by serological studies. Splenic conserving techniques may be appropriate for early disease or disease located at the perimeter of the spleen.43 Spillage of hydatid cyst contents must be meticulously avoided as anaphylactic shock may occur.

Preparation for splenectomy

Preoperative preparation for splenectomy, as for other procedures, is designed to prevent or minimise complications. Splenectomy carries the usual risk of other abdominal operations and, depending on the disease, increased risks such as bleeding, coagulopathies including disseminated intravascular coagulation, infection (both immediate and delayed) and altered cardiovascular performance.

Efforts should be made to correct all coagulopathies and optimise blood counts preoperatively if possible. In patients with ITP, laparoscopic splenectomy can be performed safely with very low platelet counts. If platelets are to be given in destructive or consumptive states, transfusion should be withheld if possible until the splenic artery is ligated to prevent the rapid breakdown of the transfused platelets.

Patients with massive splenomegaly secondary to primary myelofibrosis may have hypertrophied cardiac dysfunction, pulmonary hypertension, ascites and pleural effusions. The patient’s cardiac and pulmonary conditions should be optimised preoperatively. Appropriate preoperative antibiotics should be given to reduce the risk of infection, particularly in immunocompromised states.

Technique

Open splenectomy

Open splenectomy remains the standard for trauma surgery and should be considered in patients with massive splenomegaly or portal hypertension. The patient is placed in the supine position and prepped from nipples to pubis. An upper midline or left subcostal incision may be used. Our preference is for an upper midline approach, which may be extended in the case of massive splenomegaly. Four-quadrant packing can control traumatic bleeding temporarily. Once packs are removed sequentially and bleeding controlled, the spleen is mobilised from its lateral attachments. The hilum may be compressed by the surgeon’s hands to secure haemostasis while the remaining vessels are controlled. The remaining vascular attachments are divided and the spleen removed. Haemostasis is ensured, in particular by inspecting the ligated short gastric vessels.

Alternatively, early entrance to the lesser sac and ligation of the splenic hilum facilitates platelet transfusions as necessary, as well as control of bleeding as the spleen is further mobilised. Hilar vessels are divided between clamps and ligated or divided with a linear stapler when appropropriate. Accessory spleens should be sought and removed if surgery is designed to correct a destructive or sequestration state.

Laparoscopic splenectomy

The operative goal of laparoscopic splenectomy is circumferential mobilisation of the splenic hilum for transection. Reported techniques vary in the sequence in which the ligaments are divided, but all procedures involve the same steps.46,47 The patient is placed in the right lateral semidecubitus position and is rolled back slightly from full lateral decubitus so that the midline is exposed should urgent conversion to open surgery be required. The surgeon and camera operator stand in front of the patient and one assistant stands behind the patient. We prefer a five-port technique but others report a four-port technique.47 The omentum and transverse mesocolon are examined for accessory spleens. A wary eye is kept to identify accessory spleens throughout the procedure. Steps of dissection are illustrated in Figs 9.19.6.46 Dissection begins by dividing the splenocolic ligament and then proceeds anteriorly. The lesser sac is opened and the gastrosplenic ligament, including the short gastric vessels, is divided. The main splenic artery is isolated and ligated, if feasible, to facilitate later hilar transaction and decrease bleeding at the staple line. The lateral attachments are divided. Some surgeons will leave the highest end of the splenophrenic ligament attached until after hilar transection to prevent rotation; this is known as the ‘hanged spleen’ technique.48

The hilar vessels are freed from the pancreas and staple ligation is performed. The hilum may also be controlled using clips or energy devices. The spleen is placed into a bag and morcellated after the open end of the bag is brought through a trocar site.

Resection of large spleens is facilitated by rotating the patient more towards a supine position to enhance exposure of the splenic artery. The length of the spleen is often a misleading indicator of the success of the laparoscopic approach. More often the bulk of the spleen, as assessed by its anterior–posterior and lateral–medial dimensions, has a greater effect on exposure. Hand-assisted techniques are valuable aids for removing larger spleens, allowing safer dissection of the hilum and easier vascular control should trouble arise. The spleen may be removed intact through the lower abdominal hand incision or morcellated as needed. Spleens that are so large as to prevent creation of a laparoscopic working space should be removed using an open approach.

Most patients that undergo laparoscopic splenectomy for ITP leave the hospital on the day following surgery. Recovery varies with greater degrees of splenomegaly or hypersplenism.

Summary

Laparoscopic splenectomy is the preferred method of splenic removal for most haematological conditions. Hand-assisted laparoscopic splenectomy may be useful in cases of significant splenomegaly. Open splenectomy is reserved for trauma, extreme splenomegaly and at the discretion of the surgeon. Attention to preoperative preparation, meticulous technique and careful postoperative care allow excellent results for these procedures.

References

1. McClusky, D.A., 3rd., Skandalakis, L.J., Colborn, G.L., et al, Tribute to a triad: history of splenic anatomy, physiology, and surgery – part 1. World J Surg 1999; 23:311–325. 9933705

2. McClusky, D.A., 3rd., Skandalakis, L.J., Colborn, G.L., et al, Tribute to a triad: history of splenic anatomy, physiology, and surgery – part 2. World J Surg 1999; 23:514–526. 10085403

3. Galvan, D.A., Peitzman, A.B., Failure of nonoperative management of abdominal solid organ injuries. Curr Opin Crit Care 2006; 12:590–594. 17077692

4. Kyaw, M.H., Holmes, E.M., Toolis, F., et al, Evaluation of severe infection and survival after splenectomy. Am J Med 2006; 119:276.e1–276.e7. 16490477

5. Davies, J.M., Barnes, R., Milligan, D., Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clin Med 2002; 2:440–443. 12448592

6. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force, Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Br Med J 1996; 312:430–434. 8601117 Evidence-based guidelines outlining prevention of sepsis in splenectomised patients.

7. Mourtzoukou, E.G., Pappas, G., Peppas, G., et al, Vaccination of asplenic or hyposplenic adults. Br J Surg 2008; 95:273–280. 18278784 Evidence-based guidelines outlining prevention of sepsis in splenectomised patients.

8. Shatz, D.V., Schinsky, M.F., Pais, L.B., et al, Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy. J Trauma 1998; 44:760–766. 9603075

9. Kyaw, M.H., Holmes, E.M., Chalmers, J., et al, A survey of vaccine coverage and antibiotic prophylaxis in splenectomised patients in Scotland. J Clin Pathol 2002; 55:472–474. 12037033

10. Savage, S.A., Zarzaur, B.L., Magnotti, L.J., et al, The evolution of blunt splenic injury: resolution and progression. J Trauma 2008; 64:1085–1091. 18404079

11. Schroeppel, T.J., Croce, M.A., Diagnosis and management of blunt abdominal solid organ injury. Curr Opin Crit Care 2007; 13:399–404. 17599009

12. American College of Surgeons. Advanced trauma life support for doctors, 8th ed. Chicago: American College of Surgeons; 2008.

13. Rozycki, G.S., Surgeon-performed ultrasound: its use in clinical practice. Ann Surg 1998; 228:16–28. 9671062

14. Tinkoff, G., Esposito, T.J., Reed, J., et al, American Association for the Surgery of Trauma Organ Injury Scale I: spleen, liver, and kidney, validation based on National Trauma Data Bank. J Am Coll Surg 2008; 207:646–655. 18954775

15. Harbrecht, B.G., Peitzman, A.B., Rivera, L., et al, Contribution of age and gender to outcome of blunt splenic injury in adults: multicenter study of the Eastern Association for the Surgery of Trauma. J Trauma 2001; 51:887–895. 11706335

16. McIntyre, L.K., Schiff, M., Jurkovich, G.J., Failure of nonoperative management of splenic injuries: causes and consequences. Arch Surg 2005; 140:563–569. 15967903

17. Smith, J.S., Jr., Wengrovitz, M.A., DeLong, B.S., Prospective validation of criteria, including age, for safe, nonsurgical management of the ruptured spleen. J Trauma 1992; 33:363–369. 1404503

18. Patient Care Committee of the Society for Surgery of the Alimentary Tract (SSAT), Surgical treatment of injuries and diseases of the spleen. J Gastrointest Surg 2005; 9:453–454. 15906472

19. Sclafani, S.J., Shaftan, G.W., Scalea, T.M., et al, Nonoperative salvage of computed tomography-diagnosed splenic injuries: utilization of angiography for triage and embolization for hemostasis. J Trauma 1995; 39:818–827. 7473996

20. Cooney, R., Ku, J., Cherry, R., et al, Limitations of splenic angioembolization in treating blunt splenic injury. J Trauma 2005; 59:926–932. 16374283

21. Haan, J., Ilahi, O.N., Kramer, M., et al, Protocol-driven nonoperative management in patients with blunt splenic trauma and minimal associated injury decreases length of stay. J Trauma 2003; 55:317–322. 12913643

22. Barquist, E.S., Pizano, L.R., Feuer, W., et al, Inter- and intrarater reliability in computed axial tomographic grading of splenic injury: why so many grading scales? J Trauma 2004; 56:334–338. 14960976

23. Harbrecht, B.G., Ko, S.H., Watson, G.A., et al, Angiography for blunt splenic trauma does not improve the success rate of nonoperative management. J Trauma 2007; 63:44–49. 17622867

24. Cassar, K., Munro, A., Iatrogenic splenic injury. J R Coll Edinb 2002; 47:731–741. 12510965

25. Merchea, A., Dozois, E.J., Wang, J.K., et al, Anatomic mechanisms for splenic injury during colorectal surgery. Clin Anat. 2012;25(2):212–217. 21800366

26. Malek, M.M., Greenstein, A.J., Chin, E.H., et al, Comparison of iatrogenic splenectomy during open and laparoscopic colon resection. Surg Laparosc Endosc Percutan Tech 2007; 17:385–387. 18049397

27. Chung, B.I., Desai, M.M., Gill, I.S., Management of intraoperative splenic injury during laparoscopic urological surgery. BJU Int 2011; 108:572–576. 21062394

28. Holubar, S.D., Wang, J.K., Wolff, B.G., et al, Splenic salvage after intraoperative splenic injury during colectomy. Arch Surg 2009; 144:1040–1045. 19917941

29. Ruggeri, M., Rodeghiero, F., Tosetto, A. Steroids and intravenous immune globulines for the treatment of acute idiopathic thrombocytopenic purpura in adults. Cochrane Database Syst Rev. 4, 2007. Evidence base for medical therapy of ITP.

30. Portielje, J.E., Westendorp, R.G., Kluin-Nelemans, H.C., et al, Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 2001; 97:2549–2554. 11313240

31. Provan, D., Stasi, R., Newland, A.C., et al, International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010; 115:168–186. 19846889 Evidence base for medical therapy of ITP.

32. Duperier, T., Felsher, J., Brody, F., Laparoscopic splenectomy for Evans syndrome. Surg Laparosc Endosc Percutan Tech 2003; 13:45–47. 12598759

33. Smedley, J.C., Bellingham, A.J., Current problems in haematology. 2: Hereditary spherocytosis. J Clin Pathol 1991; 44:441–444. 2066420

34. Bolton-Maggs, P.H., Langer, J.C., Iolascon, A., et al, Guidelines for the diagnosis and management of hereditary spherocytosis – 2011 update. Br J Haematol 2011; 156:37–49. 22055020 Evidence base for medical therapy of hereditary spherocytosis.

35. Stoehr, G.A., Stauffer, U.G., Eber, S.W., Near-total splenectomy: a new technique for the management of hereditary spherocytosis. Ann Surg 2005; 241:40–47. 15621989

36. Bader-Meunier, B., Gauthier, F., Archambaud, F., et al, Long-term evaluation of the beneficial effect of subtotal splenectomy for management of hereditary spherocytosis. Blood 2001; 97:399–403. 11154215

37. Buesing, K.L., Tracy, E.T., Kiernan, C., et al, Partial splenectomy for hereditary spherocytosis: a multi-institutional review. J Pediatr Surg 2011; 46:178–183. 21238662

38. Locatelli, F., De Stefano, P., Innovative approaches to hematopoietic stem cell transplantation for patients with thalassaemia. Haematologica 2005; 90:1592–1594. 16330431

39. Al-Salem, A.H., Indications and complications of splenectomy for children with sickle cell disease. J Pediatr Surg 2006; 41:1909–1915. 17101369

40. Rescorla, F.J., West, K.W., Engum, S.A., et al, Laparoscopic splenic procedures in children: experience in 231 children. Ann Surg 2007; 246:683–688. 17893505

41. Willcox, T.M., Speer, R.W., Schlinkert, R.T., et al, Hemangioma of the spleen: presentation, diagnosis, and management. J Gastrointest Surg 2000; 4:611–613. 11307096

42. Hansen, M.B., Moller, A.C., Splenic cysts. Surg Laparosc Endosc Percutan Tech 2004; 14:316–322. 15599294

43. Kalinova, K., Stefanova, P., Bosheva, M., Surgery in children with hydatid disease of the spleen. J Pediatr Surg 2006; 41:1264–1266. 16818060

44. Habermalz, B., Sauerland, S., Decker, G., et al, Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 2008; 22:821–848. 18293036

45. Park, A.E., Birgisson, G., Mastrangelo, M.J., et al, Laparoscopic splenectomy: outcomes and lessons learned from over 200 cases. Surgery 2000; 128:660–667. 11015100

46. Schlinkert, R.T., Teotia, S.S., Laparoscopic splenectomy. Arch Surg 1999; 134:99–103. 9927141

47. Katkhouda, N., Hurwitz, M.B., Rivera, R.T., et al, Laparoscopic splenectomy: outcome and efficacy in 103 consecutive patients. Ann Surg 1998; 228:568–578. 9790346

48. Delaitre, B., Laparoscopic splenectomy. The “hanged spleen” technique. Surg Endosc 1995; 9:528–529. 7676379